$2.83
3.41% yesterday
Nasdaq, Aug 18, 10:19 pm CET
ISIN
US00091E1091
Symbol
ABSI

Absci Corp Stock price

$2.83
-0.29 9.29% 1M
-2.96 51.12% 6M
+0.21 8.02% YTD
-1.34 32.13% 1Y
-1.40 33.10% 3Y
-13.17 82.31% 5Y
-13.17 82.31% 10Y
-13.17 82.31% 20Y
Nasdaq, Closing price Mon, Aug 18 2025
-0.10 3.41%
ISIN
US00091E1091
Symbol
ABSI
Industry

Key metrics

Basic
Market capitalization
$437.4m
Enterprise Value
$306.6m
Net debt
positive
Cash
$134.0m
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative | negative
P/S
105.6 | 55.3
EV/Sales
74.1 | 38.7
EV/FCF
negative
P/B
2.2
Financial Health
Equity Ratio
83.9%
Return on Equity
-57.6%
ROCE
-
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$4.1m | $7.9m
EBITDA
$-106.0m | $-99.9m
EBIT
$-118.7m | $-112.0m
Net Income
$-113.3m | -
Free Cash Flow
$-76.7m
Growth (TTM | estimate)
Revenue
27.4% | 74.7%
EBITDA
-25.5% | -6.1%
EBIT
-20.8% | -4.2%
Net Income
-22.8% | -
Free Cash Flow
-26.5%
Margin (TTM | estimate)
Gross
-
EBITDA
-2,562.4% | -1,261.9%
EBIT
-2,868.3%
Net
-2,737.9% | -
Free Cash Flow
-1,854.2%
More
EPS
$-0.9
FCF per Share
-
Short interest
25.0%
Employees
157
Rev per Employee
$30.0k
Show more

Is Absci Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,018 stocks worldwide.

Absci Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Absci Corp forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a Absci Corp forecast:

Buy
93%
Hold
7%

Financial data from Absci Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
4.14 4.14
27% 27%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 36 36
2% 2%
871%
- Research and Development Expense 72 72
41% 41%
1,735%
-106 -106
26% 26%
-2,561%
- Depreciation and Amortization 13 13
8% 8%
306%
EBIT (Operating Income) EBIT -119 -119
21% 21%
-2,867%
Net Profit -113 -113
23% 23%
-2,737%

In millions USD.

Don't miss a Thing! We will send you all news about Absci Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Absci Corp Stock News

Neutral
Seeking Alpha
6 days ago
Absci Corporation (NASDAQ:ABSI ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Alexander Khan - VP of Finance & Head of Investor Relations Christian Stegmann - Senior Vice President of Drug Creation Sean McClain - Founder, CEO, President & Director Zachariah Jonasson - Chief Business Officer & CFO Conference Call Participants Alexander Xenakis - Unidentified C...
Neutral
GlobeNewsWire
6 days ago
Strengthened balance sheet raising approximately $64 million in gross proceeds in July 2025; cash, cash equivalents, and short-term investments now sufficient to fund operations into the first half of 2028
Neutral
GlobeNewsWire
12 days ago
BARCELONA, Spain and VANCOUVER, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Almirall (BME: ALM), a global biopharmaceutical company focused on medical dermatology, and Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the expansion of their ongoing AI Drug Discovery collaboration with Almirall's sele...
More Absci Corp News

Company Profile

AbSci Corp. engages in the development of protein biomanufacturing technology. It offers SoluPro, an all-in-one protein expression platform which produces complex proteins using simplest and least expensive organism. The company was founded by Sean Mcclain and Mark Valasek in 2011 and is headquartered in Vancouver, WA.

Head office United States
CEO Sean McClain
Employees 157
Founded 2011
Website www.absci.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today